Current and historical daily PE Ratio for Guizhou Sanli Pharmaceutical Co Ltd (
SHSE:603439
) from 2020 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Guizhounli Pharmaceutical stock (SHSE:603439) PE ratio as of Jun 20 2024 is 17.71.
More Details
Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) PE Ratio (TTM) Chart
Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 1005
- 1
- 2
- 3
- 4
- 5
- 6
- 12
Guizhounli Pharmaceutical PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | 17.7 | 2024-04-12 | 20.8 |
2024-06-19 | 18.0 | 2024-04-11 | 20.7 |
2024-06-18 | 18.8 | 2024-04-10 | 20.9 |
2024-06-17 | 19.0 | 2024-04-09 | 21.5 |
2024-06-14 | 19.1 | 2024-04-08 | 20.9 |
2024-06-13 | 19.1 | 2024-04-03 | 21.6 |
2024-06-12 | 19.7 | 2024-04-02 | 21.9 |
2024-06-11 | 19.8 | 2024-04-01 | 22.5 |
2024-06-07 | 19.8 | 2024-03-29 | 22.3 |
2024-06-06 | 19.4 | 2024-03-28 | 22.1 |
2024-06-05 | 20.0 | 2024-03-27 | 22.3 |
2024-06-04 | 20.7 | 2024-03-26 | 22.5 |
2024-06-03 | 20.6 | 2024-03-25 | 22.6 |
2024-05-31 | 21.0 | 2024-03-22 | 23.4 |
2024-05-30 | 20.7 | 2024-03-21 | 24.1 |
2024-05-29 | 20.8 | 2024-03-20 | 24.3 |
2024-05-28 | 20.9 | 2024-03-19 | 24.4 |
2024-05-27 | 21.4 | 2024-03-18 | 24.9 |
2024-05-24 | 21.0 | 2024-03-15 | 24.4 |
2024-05-23 | 21.3 | 2024-03-14 | 24.5 |
2024-05-22 | 21.5 | 2024-03-13 | 24.3 |
2024-05-21 | 21.5 | 2024-03-12 | 24.7 |
2024-05-20 | 21.9 | 2024-03-11 | 23.0 |
2024-05-17 | 21.9 | 2024-03-08 | 22.7 |
2024-05-16 | 21.9 | 2024-03-07 | 22.5 |
2024-05-15 | 22.4 | 2024-03-06 | 22.5 |
2024-05-14 | 23.0 | 2024-03-05 | 23.0 |
2024-05-13 | 22.6 | 2024-03-04 | 23.8 |
2024-05-10 | 22.0 | 2024-03-01 | 22.4 |
2024-05-09 | 22.5 | 2024-02-29 | 22.2 |
2024-05-08 | 22.3 | 2024-02-28 | 21.4 |
2024-05-07 | 22.8 | 2024-02-27 | 23.1 |
2024-05-06 | 22.1 | 2024-02-26 | 22.4 |
2024-04-30 | 21.8 | 2024-02-23 | 22.1 |
2024-04-29 | 20.9 | 2024-02-22 | 22.1 |
2024-04-26 | 21.4 | 2024-02-21 | 21.8 |
2024-04-25 | 21.3 | 2024-02-20 | 22.0 |
2024-04-24 | 21.1 | 2024-02-19 | 21.1 |
2024-04-23 | 21.1 | 2024-02-08 | 21.5 |
2024-04-22 | 20.8 | 2024-02-07 | 19.7 |
2024-04-19 | 20.4 | 2024-02-06 | 18.8 |
2024-04-18 | 20.5 | 2024-02-05 | 17.8 |
2024-04-17 | 20.1 | 2024-02-02 | 19.4 |
2024-04-16 | 19.6 | 2024-02-01 | 21.4 |
2024-04-15 | 20.4 | 2024-01-31 | 20.8 |
Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Guizhou Sanli Pharmaceutical Co Ltd
ISIN : CNE1000040B4
Share Class Description:
SHSE:603439: Class ACompare
Compare
Traded in other countries / regions
603439.China IPO Date
2020-04-28Description
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.